Association of genetic polymorphism in the promoter region of CD209 gene and susceptibility to invasive pulmonary aspergillosis;Asociación de un polimorfismo genético en la región promotora del gen cd209 y propensión a la aspergilosis pulmonar invasiva

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 32, Issue SUPPL. A, 2010, Pages 9-13

  Sainz, J ^a,b   Segura Catena, J ^b   Jurado, M ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; GALACTOMANNAN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; FUNGUS ANTIGEN; LECTIN; MANNAN;

ALLELE; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEMATOLOGIC MALIGNANCY; HETEROZYGOTE; HUMAN; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BLOOD DISEASE; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR;

ANTIGENS, FUNGAL; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNITY, INNATE; INVASIVE PULMONARY ASPERGILLOSIS; LECTINS, C-TYPE; MANNANS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; RISK ASSESSMENT; RISK FACTORS;

EID: 79954443629     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1994.
2. Chamilos, G., Luna, M., Lewis, R.E., et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006, 91: 988-91.
3. Clark, T.A., Hajjeh, R.A. Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002, 15: 569.
4. Working Group European Aspergillus PCR Initiative: http://www. eapcri.eu/.
5. Aisner, J., Murillo, J., Schmipff, S.C., Steere, A.C. Invasive aspergillosis in acute leukaemia: correlation with nose cultures and antibiotics use. Ann Intern Med 1979, 90: 4.
6. Palmer, L.B., Greenberg, H.E., Schiff, M. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 1991, 46: 15.
7. Offner, F., Cordonnier, C., Ljungman, P., et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998, 26: 1098-103.
8. Sainz, J., Salas-Alvarado, I., López-Fernández, E., et al. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int J Immunol Pharmacol 2009, 22: 557-65.
9. Sainz, J., Pérez, E., Gómez-Lopera, S., Jurado, M. IL1 gene cluster polymorphisms and its haplotypes may predict the risk to develop invasive pulmonary aspergillosis and modulate C-reactive protein level. J Clin Immunol 2008, 28: 473-85.
10. Sainz, J., Pérez, E., Gómez-Lopera, S., et al. Genetic variants of IL6 gene promoter influence on C-reactive protein levels but are not associated with susceptibility to invasive pulmonary aspergillosis in hematological patients. Cytokine 2008, 41: 268-78.
11. Sainz, J., Hassan, L., Pérez, E., et al. Interleukin-10 polymorphisms as risk factor to develop invasive pulmonary aspergillosis. Immunol Lett 2007, 109: 76-82.
12. Sainz, J., Pérez, E., Hassan, L., et al. VNTR of TNF receptor 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergilosis. Human Immunol 2007, 68: 41-50.
13. Serrano-Gómez, D., Leal, J.A., Corbí, A.L. DC-SIGN mediates the binding of Aspergillus fumigatus and keratinophylic fungi by human dendritic cells. Immunobiology 2005, 210: 175-83.
14. Geijtenbeek, T.B., Van Vliet, S.J., Koppel, E.A., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003, 197: 7.
15. Vannberg, F.O., Chapman, S.J., Khor, C.C., et al. CD209 genetic polymorphism and tuberculosis disease. PLoS One 2008, 3: e1388.
16. Sakuntabhai, A., Turbpaiboon, C., Casademont, I., et al. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005, 37: 507-13.
17. Selvaraj, P., Alagarasu, K., Swaminathan, S., et al. CD209 gene polymorphisms in South Indian HIV and HIV-TB patients. Infect Genet Evol 2009, 9: 256-62.
18. Ascioglu, S., Rex, J.H., de Pauw, B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and haematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002, 34: 7-14.
19. Latge, J. P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999, 12: 310-50.
20. den Dunnen, J., Gringhuis, S.I., Geijtenbeek, T.B. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother 2009, 58: 1149-57.